Maximus, Inc. (NYSE:MMS) Shares Purchased by Man Group plc

Man Group plc raised its position in Maximus, Inc. (NYSE:MMS - Free Report) by 53.5% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 223,297 shares of the health services provider's stock after purchasing an additional 77,810 shares during the quarter. Man Group plc owned 0.39% of Maximus worth $16,669,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also modified their holdings of the company. Nomura Holdings Inc. acquired a new stake in Maximus during the 4th quarter worth approximately $595,000. Occudo Quantitative Strategies LP purchased a new stake in Maximus during the fourth quarter worth approximately $1,014,000. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its position in shares of Maximus by 2.6% in the fourth quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 34,255 shares of the health services provider's stock worth $2,557,000 after acquiring an additional 869 shares in the last quarter. Lazard Asset Management LLC raised its stake in shares of Maximus by 477.8% in the 4th quarter. Lazard Asset Management LLC now owns 101,915 shares of the health services provider's stock valued at $7,607,000 after acquiring an additional 84,277 shares during the period. Finally, LRI Investments LLC raised its stake in shares of Maximus by 44.1% in the 4th quarter. LRI Investments LLC now owns 1,638 shares of the health services provider's stock valued at $122,000 after acquiring an additional 501 shares during the period. 97.21% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling

In related news, Director Jan Madsen sold 2,439 shares of the stock in a transaction dated Tuesday, March 18th. The stock was sold at an average price of $67.71, for a total value of $165,144.69. Following the completion of the transaction, the director now owns 18,097 shares of the company's stock, valued at approximately $1,225,347.87. This represents a 11.88% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this link. 1.60% of the stock is currently owned by insiders.

Analyst Upgrades and Downgrades

Separately, Wall Street Zen cut shares of Maximus from a "buy" rating to a "hold" rating in a research report on Thursday, May 15th.

Maximus Stock Down 0.2%

Shares of NYSE MMS traded down $0.13 on Thursday, hitting $73.56. The company had a trading volume of 31,224 shares, compared to its average volume of 559,494. The company has a quick ratio of 1.72, a current ratio of 1.72 and a debt-to-equity ratio of 0.82. Maximus, Inc. has a 12-month low of $63.77 and a 12-month high of $93.97. The firm has a market capitalization of $4.14 billion, a P/E ratio of 15.82 and a beta of 0.61. The business has a 50 day moving average of $69.18 and a two-hundred day moving average of $72.50.

Maximus (NYSE:MMS - Get Free Report) last released its quarterly earnings results on Thursday, May 8th. The health services provider reported $2.01 earnings per share for the quarter, topping analysts' consensus estimates of $1.37 by $0.64. Maximus had a return on equity of 21.95% and a net margin of 5.28%. The firm had revenue of $1.36 billion during the quarter, compared to analysts' expectations of $1.29 billion. During the same quarter in the prior year, the business earned $1.57 EPS. Maximus's quarterly revenue was up 1.0% compared to the same quarter last year. As a group, equities research analysts forecast that Maximus, Inc. will post 6.15 earnings per share for the current fiscal year.

Maximus Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Saturday, May 31st. Investors of record on Thursday, May 15th will be issued a dividend of $0.30 per share. This represents a $1.20 dividend on an annualized basis and a yield of 1.63%. The ex-dividend date is Thursday, May 15th. Maximus's payout ratio is 23.86%.

Maximus Company Profile

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.